Skip to content
MedsAcross

Brand family

Tudriqev

United States
Presentations
2
Markets
1

Tudriqev is a brand of Vusolimogene oderparepvec marketed by Replimune, with 2 presentations listed and registered in United States. Each presentation below has its own page with packs, documents and availability for export supply from India.

Active ingredient (INN)
Vusolimogene oderparepvec
Brand owner
Replimune
Registered in
United States
Strengths and forms
1000000 PFU/mL injectable suspension, 10000000 PFU/mL injectable suspension

All presentations

MedicineManufacturerRegisterAvailability
Tudriqev 1000000 PFU/mL injectable suspensionIntratumor Cold chainReplimuneUS FDAAvailable on request
Tudriqev 10000000 PFU/mL injectable suspensionIntratumor Cold chainReplimuneUS FDAAvailable on request

Brand names and trademarks belong to their owners and are used only to identify products.

Request Tudriqev

Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.